Uterine fibroid therapy: the pharmacokinetic considerations-Reference-Cited by-同舟云学术

Uterine fibroid therapy: the pharmacokinetic considerations

Published:2018-08-02 Issue:9 Volume:14 Page:887-889
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Ali Mohamed¹²,Al-Hendy Ayman¹

Affiliation:

1. Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL, USA

2. Clinical Pharmacy department, Faculty of pharmacy, Ain Shams University, Cairo, Egypt

Funder

the National Institute of Health

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2018.1506766

Reference15 articles.

1. Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids†

2. Uterine leiomyoma: understanding the impact of symptoms on womens’ lives

3. Successes and failures of uterine leiomyoma drug discovery

4. LA. LUPRON DEPOT® 3.75 mg - Food and Drug administration (FDA) drugs. 2011. [cited 2018 May]. Available from: https://wwwaccessdatafdagov/drugsatfda_docs/label/2011/019943s032,020011s039lblpdf.

5. Add-back therapy with GnRH analogues for uterine fibroids

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental and new investigational drugs for the treatment of uterine fibroids;Expert Opinion on Investigational Drugs;2024-04-17

2. Effect of a Self-Made Herbal Decoction Containing Angelica sinensis Combined with an Enhanced Recovery After Surgery Nursing Model on Anxiety, Depression, and Ovarian Function in Patients Undergoing Myomectomy;Journal of Biobased Materials and Bioenergy;2023-12-01

3. Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids;Expert Opinion on Drug Metabolism & Toxicology;2022-08-03

4. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment;Endocrine Reviews;2021-11-06

5. Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview;Clinical Pharmacokinetics;2021-09-27